Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study to Evaluate Safety, Tolerance and Pharmacokinetics of SY-007 After Single-dose Incremental Intravenous Injection in Healthy Subjects

NCT04111523 is registered in ClinicalTrials.gov with Suzhou Yabao Pharmaceutical R&D Co., Ltd. as lead sponsor.

NCT NCT04111523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04111523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study to Evaluate Safety, Tolerance and Pharmacokinetics of SY-007 After Single-dose Incremental Intravenous Injection in Healthy Subjects
Lead sponsor
Suzhou Yabao Pharmaceutical R&D Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
March 5, 2019
Completion date
May 26, 2020
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral apoplexy